UK 22:41 Wednesday, 30 September 2026
Breaking news and expert analysis on fast-moving AIM and LSE listed shares
Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
Over the the past decade Nigel Somerville and I have warned folks about this dog with fleas, almost as many times as I have had inappropriate thoughts about Cheryl Cole. With the shares in the minus 99% club, I guess we are already vindicated but today comes yet more bad news for Advanced Oncotherapy (AVO). As Old Mother Mike Walters, who is the sort of man who would have tipped this cash guzzling POS which has deceived its investors on a serial basis, would have said as he apologised for another duff share tip: “Oh dear, Oh dear” We start with the dreaded words “strategic review.”
Already a member? Sign in
• All premium articles
• Tom Winnifrith’s Bearcast
• Access to all the entire nearly 13 year archive
• ShareProphets Daily Newsletter
Cancel any time
This area of the ShareProphets.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ShareProphets.com. ShareProphets.com does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ShareProphets.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ShareProphets.com and is not intended to be relied upon by users in making (or refraining from making) any investment decisions.
